We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+13.82%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$13B
AUM Growth
+$1.56B
Cap. Flow
+$261M
Cap. Flow %
2.02%
Top 10 Hldgs %
17.05%
Holding
1,179
New
174
Increased
377
Reduced
434
Closed
179

Top Buys

Rank Stock Value
1
COST icon
Costco
COST
+$128M
2
EA icon
Electronic Arts
EA
+$79.4M
3
BMY icon
Bristol-Myers Squibb
BMY
+$75M
4
TGT icon
Target
TGT
+$74.4M
5
AMZN icon
Amazon
AMZN
+$64.3M

Sector Composition

Rank Sector Weight
1 Technology 22.12%
2 Healthcare 14.04%
3 Consumer Discretionary 13.03%
4 Financials 12.63%
5 Industrials 9.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSX icon
976
CSX Corp
CSX
$94.2B
$207K ﹤0.01%
+6,426
New +$196K
MSBI icon
977
Midland States Bancorp
MSBI
$707M
$203K ﹤0.01%
+7,300
New +$169K
OPY icon
978
Oppenheimer Holdings
OPY
$1.2B
$202K ﹤0.01%
+5,049
New +$187K
SYNC
979
DELISTED
Synacor, Inc.
SYNC
$194K ﹤0.01%
88,655
-151,339
-63% -$296K
OPBK icon
980
OP Bancorp
OPBK
$241M
$191K ﹤0.01%
18,134
-592
-3% -$5.45K
TRC icon
981
Tejon Ranch
TRC
$467M
$170K ﹤0.01%
+10,159
New +$167K
RVSB icon
982
Riverview Bancorp
RVSB
$109M
$163K ﹤0.01%
23,506
-113
-0.5% -$694
ESXB
983
DELISTED
Community Bankers Trust Corporation
ESXB
$159K ﹤0.01%
+18,021
New +$140K
XXII
984
22nd Century Group
XXII
$1.36M
0
LYRA
985
DELISTED
LYRA THERAPEUTICS INC
LYRA
$143K ﹤0.01%
247
+2
+0.8% +$1.25K
WNEB icon
986
Western New England Bancorp
WNEB
$295M
$139K ﹤0.01%
+16,473
New +$126K
CALC icon
987
CalciMedica
CALC
$11.3M
$136K ﹤0.01%
+1,754
New +$525K
PANL icon
988
Pangaea Logistics
PANL
$493M
$134K ﹤0.01%
42,527
+27,358
+180% +$83.1K
CRD.B icon
989
Crawford & Co Class B
CRD.B
$502M
$129K ﹤0.01%
13,330
DTIL icon
990
Precision BioSciences
DTIL
$185M
$129K ﹤0.01%
414
-2,387
-85% -$836K
INN
991
Summit Hotel Properties
INN
$743M
$125K ﹤0.01%
+12,326
New +$119K
SBT
992
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
$121K ﹤0.01%
21,324
+6,924
+48% +$36K
ELVN icon
993
Enliven Therapeutics
ELVN
$3.84B
$116K ﹤0.01%
+3,449
New +$175K
MNTX
994
DELISTED
Manitex International, Inc.
MNTX
$113K ﹤0.01%
14,300
FBIO icon
995
Fortress Biotech
FBIO
$113M
$97K ﹤0.01%
1,838
+1,102
+150% +$62.2K
MTCR
996
DELISTED
Metacrine, Inc. Common Stock
MTCR
$95K ﹤0.01%
+15,356
New +$136K
GYRE icon
997
Gyre Therapeutics
GYRE
$668M
$83K ﹤0.01%
2,195
-5,869
-73% -$268K
CHRA
998
DELISTED
Charah Solutions, Inc Common Stock
CHRA
$82K ﹤0.01%
1,688
-1,677
-50% -$63.2K
NH
999
DELISTED
NantHealth, Inc
NH
$80K ﹤0.01%
1,659
-519
-24% -$30.1K
SLNO
1000
DELISTED
Soleno Therapeutics
SLNO
$34K ﹤0.01%
1,813
-3,060
-63% -$98.6K

Similar funds

Jacobs Levy Equity Management's Q1 2021 Portfolio in Review

As of Q1 2021, Jacobs Levy Equity Management held 1,179 positions worth $13B, up 14% from $11.4B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Jacobs Levy Equity Management's Q1 2021 filing shows 174 new, 377 increased, 434 reduced and 179 closed positions. Its largest new stake was Target: 397,775 shares worth $78.8M. The largest sale was Microsoft, an estimated $124M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Jacobs Levy Equity Management's largest Q1 2021 buy was Target: 397,775 shares worth $78.8M.
  • Jacobs Levy Equity Management added most to Costco in Q1 2021, an estimated $128M increase.
  • Jacobs Levy Equity Management's biggest Q1 2021 reduction was Microsoft, cutting an estimated $124M.
  • Jacobs Levy Equity Management fully exited Starbucks in Q1 2021, selling an estimated $121M.
  • Jacobs Levy Equity Management's ten largest holdings make up 17% of its $13B portfolio in Q1 2021.
  • Jacobs Levy Equity Management opened 174 new positions and closed 179 in Q1 2021.
  • Jacobs Levy Equity Management's portfolio value rose 14% quarter-over-quarter to $13B.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2021, filed 17 May 2021.